BioHealth News Archive
Commentary: Washington wants to forfeit our best weapon against coronavirus | Columnists | elkodaily.com
Rep. Jan Schakowsky (D-IL) and several senior House lawmakers recently announced a plan to impose price controls and seize patents on any COVID-19 vaccines…
Read More
Meet the Researcher Leading NIH’s COVID-19 Vaccine Development Efforts – Government Executive
Asafe, effective vaccine is the ultimate tool needed to end the coronavirus disease 2019 (COVID-19) pandemic. Biomedical researchers are making progress every day towards…
Read More
Johns Hopkins calls new federal rules for international students ‘disturbing’ and ‘draconian’ – Baltimore Business Journal
Hopkins has the highest percentage of international students of any Maryland college. {iframe}https://www.bizjournals.com/baltimore/news/2020/07/08/hopkins-opposes-federal-rule-international-student.html{/iframe}
Read More
Where Providence Ventures is investing millions — 17 portfolio companies including Protenus
Providence Ventures was founded in 2014 and manages $300 million of venture capital in two funds. The company is affiliated with Providence, a 51-hospital…
Read MoreJohns Hopkins statement re: SEVP lawsuit filed today
BALTIMORE, July 10, 2020 /PRNewswire/ -- Johns Hopkins University filed suit in federal court Friday in an effort to stop a Trump administration rule…
Read More
Johns Hopkins’ Covid-19 map: Meet the team behind the leading resource – CNN
(CNN) - If the year 2020 is good for anything, it's the lesson that during a crisis, anyone who builds a better mousetrap will…
Read More
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding | Emergent BioSolutions Inc.
NEW YORK and GAITHERSBURG, Md. and NEW ORLEANS and LAFAYETTE, La., July 08, 2020 (GLOBE NEWSWIRE) -- The Mount Sinai Health System, Emergent BioSolutions…
Read More
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
VIENNA, AUSTRIA and GAITHERSBURG, MD, July 8, 2020 APEIRON Biologics AG (“APEIRON”), a private biotechnology company specializing in the discovery, development and commercialization of…
Read More
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine | GSK
GSK and Medicago today announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s…
Read More
Fueling an Innovation Ecosystem for Startups to Thrive – Tune In Today – Bendis to Moderate
BHI's own Rich Bendis will Moderate. Join us for a lively discussion between our region’s top innovators and connectors to hear about their efforts…
Read More
Fueling an Innovation Ecosystem for Startups to Thrive (Bendis to Moderate)
BHI's own Rich Bendis will Moderate. Join us for a lively discussion between our region’s top innovators and connectors to hear about their efforts…
Read More
The biotech IPO boom is becoming ‘historic’ as four more throw their hats in – Endpoints News
Four more US biotechs filed to go pub lic Fri day as yet more com pa nies clam ber to get through a yawn…
Read More
Johns Hopkins Medicine CEO: Predictive analytics, precision medicine and AI are the future of medicine
Paul Rothman, MD, CEO of Baltimore-based Johns Hopkins Medicine and dean of the medical faculty at Johns Hopkins University, discussed the health system's COVID-19…
Read More
Former MedImmune Employees Leading In the BioHealth Capital Region and Beyond · BioBuzz
In a recent conversation someone shared the quote “You can’t throw a stone in the BioHealth Capital Region and not hit somebody who worked…
Read More
Prestigious annual pediatric medical device competition reveals 10 finalists including BHI client Innara
WASHINGTON, June 29, 2020 /PRNewswire/ -- Ten finalists have been named in the prestigious annual "Make Your Medical Device Pitch for Kids!" competition presented…
Read More